Russell McMahen
Chief Tech/Sci/R&D Officer bij AYTU BIOPHARMA, INC.
Profiel
Russell Lee McMahen is currently the Senior Vice President-Research & Development at Aytu Biopharma, Inc. He previously worked as the Senior Vice President-Research & Development at Neos Therapeutics, Inc. from 2011 to 2021.
Prior to that, he was a Principal at IVAX Pharmaceuticals, Inc. He obtained his undergraduate degree from Louisiana Tech University.
Actieve functies van Russell McMahen
| Bedrijven | Functie | Begin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
Eerdere bekende functies van Russell McMahen
| Bedrijven | Functie | Einde |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Chief Operating Officer | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Corporate Officer/Principal | - |
Opleiding van Russell McMahen
| Louisiana Tech University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Health Technology |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
